Stroke remains one of the leading causes of morbidity and mortality worldwide. Early recognition and prompt management are crucial in mitigating the debilitating consequences of this cerebrovascular event. This paper aims to provide healthcare professionals with a comprehensive guide to identifying the early signs of stroke and its immediate management.
Stroke symptoms often appear suddenly and may vary depending on the affected brain region. The acronym FAST (Face drooping, Arm weakness, Speech difficulty, Time to call 911) is a widely used tool for early recognition. Other symptoms include sudden numbness or weakness, especially on one side of the body, confusion, trouble seeing or walking, and severe headache with no known cause. Understanding these signs is critical in reducing the time to treatment initiation.
The first step in managing a stroke is to ensure the patient's ABCs (Airway, Breathing, Circulation) are stable. Immediate neuroimaging, preferably with a non-contrast CT scan, should be performed to differentiate ischemic from hemorrhagic stroke. For eligible patients with an ischemic stroke, intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) should be initiated within 4.5 hours of symptom onset. Hemorrhagic strokes may require surgical intervention.
Following the acute phase, comprehensive rehabilitation is necessary to maximize patient recovery. This includes physiotherapy, occupational therapy, and speech-language therapy. Additionally, secondary stroke prevention strategies, such as control of modifiable risk factors (hypertension, diabetes, smoking) and the use of antiplatelet or anticoagulant therapy, should be implemented.
Early recognition and management of stroke can significantly improve patient outcomes. Healthcare professionals play a pivotal role in this process, from identifying the early warning signs to initiating appropriate treatment and ensuring comprehensive post-stroke care. Continued education and training in stroke recognition and management are essential in optimizing patient care.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation